CRVS logo

CRVS

Corvus Pharmaceuticals, Inc.NASDAQHealthcare
$14.69+1.80%ClosedMarket Cap: $1.23B

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

13

Sales

13

Buy/Sell Ratio

1.00

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Jan 30Thompson Peter A.director, 10 percent owner: Sell15,000$2.12210,000